Abstract
A ventilation agent that provides good quality lung images, which is cheap, easy to use and non-toxic, with a low radiation dose, has long been sought. Technegas, an ultrafine aerosol of technetium-99m-labelled carbon, was developed with these qualities in mind. We have studied Technegas in a clinical setting to evaluate some of these qualities. Twenty-five patients referred with a diagnosis of suspected pulmonary embolism were investigated during the same study using both krypton-81m and Technegas as ventilation agents in conjunction with99mTc-macroaggregated albumin as a perfusion agent. Technegas provided images which were of satisfactory quality. Images were obtained relatively easily and without discomfort to the patient, and Technegas has the advantage of always being available. A semi-quantitative regional assessment was employed which showed a good correlation (r = 0.499, P <0.001) between Technegas and krypton-81 m ventilation. We report on an effect not previously found to be significant, that is lung regions were better ventilated with Technegas than with krypton-81 m. This altered the diagnostic probability rating of pulmonary embolism in a number of patients (n = 3, 12%) compared with krypton-81 m. This effect was also noted in a further 8 patients (32%) without a change in the diagnostic probability. We offer possible explanations for this phenomenon.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Alderson PO, Martin EC (1987) Pulmonary embolism: diagnosis with multiple imaging modalities. Radiology 164:297–312
Alderson PO, Biello DR, Gottschalk A, Hoffer PB, Kropp SA, Lee ME, Rammana L, Siegel BA, Waxman AD (1984) Tc-99m-DTPA aerosol and radioactive gases compared as adjuncts to perfusion scintigraphy in patients with suspected pulmonary embolism. Radiology 153:515–521
Amis TC, Crawford AB, Davison A, Engel LA (1990) Distribution of inhaled 99m technetium labelled ultrafine carbon particle aerosol (Technegas) in human lungs. Eur Respir J 3(6):679–685
Bake B, Wood L, Murphy B, Macklem PT, Milic-Emili J (1974) Effect of inspiratory flow rate on regional distribution of inspired gas. J Appl Physiol 37(1):8–17
Ball WC, Stewart PB, Newsham LGS, Bates DV (1962) Regional pulmonary function studied with xenon-133. J Clin Invest 41(3):519–531
Biello DR, Mattar AG, McKnight RC, Siegel BA (1979) Ventilation-perfusion studies in suspected pulmonary embolism. Am J Radiol 133:1033–1037
Bunko H, Seto M, Kuji I, Miyauchi T, Hisada K (1991) Lung ventilation imaging with Technegas: clinical study of lung deposition and ventilation/perfusion. Kaku-Igaku 28:229–239
Burch WM, Sullivan PJ, McLaren CJ (1986) Technegas-a new ventilation agent for lung scanning. Nucl Med Commun 7:865–871
Crawford ABH, Davison A, Amis TC, Engel LA (1990) Intrapulmonary distribution of 99m technetium labelled ultrafne carbon aerosol (Technegas) in severe airflow obstruction. Eur Respir J 3(6):686–692
De Geeter F, Bossuyt A, Jonckheer M (1989) Comparison of Technegas to 81mKr as a ventilation agent. Eur J Nucl Med 15:442
Fazio F, Jones T (1975) Assessment of regional ventilation by continuous inhalation of radioactive krypton 81m. Br Med J 3:673–676
Fazio F, Wollmer P, Lavender JP, Barr MM (1982) Clinical ventilation imaging with In-113m aerosol: a comparison with Kr-81m. J Nucl Med 23:306–314
Hilson AJW, Pavia D, Diamond PD, Agnew JE (1989) An ultrafine 99m-Tc-aerosol (Technegas) for lung ventilation scintigraphy —a comparison with Kr-81m. J Nucl Med 30:744
Isawa T, Teshima T, Anazawa Y, Miki M, Motomiya M (1991) Technegas for inhalation lung imaging. Nucl Med Commun 12:47–55
James JM, Herman KJ, Lloyd JJ, Shields RA, Testa HJ, Church S, Stretton TB (1991a) Evaluation of 99Tcm Technegas ventilation scintigraphy in the diagnosis of pulmonary embolism. Br J Radiol 64:711–719
James JM, Prescott MC, Leahy BC, Lloyd JJ, Shields RA, Testa HJ (1991b) Hypoxia during Technegas inhalation. Nucl Med Commun 12:287
Kropp J, Buhr W, Biersack HJ (1989) Lung inhalation scintigraphy in newborns. A study with the new tracer Technegas. J Nucl Med 30:744
Mannting F, Morgan MG, Hedenstrom H, Maripuu E, Hedenstierna G (1990) A comparative study of Xe-133 and Tc-99m-gas for assessment of regional ventilation. Eur J Nucl Med 16:429
Monaghan P, IPC Murray, Mackey DWJ, Van-der-Wall H, Walker BM, Jones PD (1991) An improved radionuclide technique for the detection of altered pulmonary permeability. J Nucl Med 32:1945–1949
Murray IPC (1991) Clinical experience with Technegas. Clin Nucl Med 16:247–250
Peltier P, De Faucal P, Chetanneau A, Chatal JF (1990) Comparison of technetium-99m aerosol and krypton-81m in ventilation studies for the diagnosis of pulmonary embolism. Nucl Med Commun 11:631–638
Rimkus DS, Ashburn WL (1990) Lung ventilation scanning with a new carbon particle radioaerosol (Technegas). Clin Nucl Med 15:222–226
Secker Walker RH, Jackson JA, Goodwin J (1970) Resolution of pulmonary embolism. Br Med J 4:135–139
Strong JC, Agnew JE (1989) The particle size distribution of technegas and its influence on regional lung deposition. Nucl Med Comm 10:425–430
Sullivan PJ, Burke WM, Burch WM, Lomas FE (1988) A clinical comparison of Technegas and xenon-133 in 50 patients with suspected pulmonary embolus. Chest 94:300–304
White PG, Hayward MWJ, Cooper T (1991) Ventilation agents —what agents are currently used? Nucl Med Commun 12:349–352
Zwinenburg A, Royen EV, Dongen AV, Zanin D (1990) Experience with 99mTc-Technegas as a ventilation tracer; comparison with 81mKr-gas. Eur J Nucl Med 16:440
Author information
Authors and Affiliations
Additional information
Offprint requests to: S.E.M. Clarke
Rights and permissions
About this article
Cite this article
Cook, G., Clarke, S.E.M. An evaluation of Technegas as a ventilation agent compared with krypton-81 m in the scintigraphic diagnosis of pulmonary embolism. Eur J Nucl Med 19, 770–774 (1992). https://doi.org/10.1007/BF00182818
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00182818